Global Pulse

分类： health

  • UAE recalls some Nestle products: How to identify if your infant formula is impacted

    UAE recalls some Nestle products: How to identify if your infant formula is impacted

    In a significant food safety development, Nestlé has announced a widespread recall of multiple infant formula products across eight Middle Eastern and North African countries. The precautionary measure comes after the discovery of potential cereulide toxin contamination in specific production batches, linked to traces of Bacillus cereus bacteria in raw materials.

    The United Arab Emirates’ Emirates Drug Establishment confirmed the recall late Wednesday, identifying affected products including NAN Comfort 1, NAN Optipro 1, NAN Supreme Pro 1, 2 and 3, Isomil Ultima 1, 2 and 3, and Alfamino formulas. The contamination risk stems from arachidonic acid (ARA) oil, an ingredient used in numerous infant nutrition products globally.

    Gulf Cooperation Council members UAE, Saudi Arabia, Kuwait, and Qatar have officially issued recalls, alongside Bahrain, Egypt, Iran, and Oman. While no confirmed illnesses or adverse events have been reported to date, health authorities emphasize the potential health risks. Cereulide exposure can cause gastrointestinal symptoms including nausea, vomiting, and abdominal cramps in infants.

    Consumers are urged to immediately check their formula containers for batch codes located at the base of the tin. Nestlé has published comprehensive lists of affected batch numbers, which vary by country. Those identifying recalled products should contact their local Nestlé Consumer Engagement Center for refunds or replacements, potentially providing photographic evidence of the product and batch code.

    The multinational corporation is collaborating with regional health authorities to implement appropriate safety measures in accordance with local food safety regulations. Company representatives stress that this proactive recall demonstrates their commitment to consumer protection, though they note the contamination was detected before any health incidents were reported.

    Local Nestlé teams are maintaining updated information on brand-specific websites to keep consumers informed throughout the recall process. Health authorities continue to monitor the situation while reassuring the public that swift action has been taken to mitigate potential health risks.

  • 4 GCC countries recall batches of Nestle’s infant formula

    4 GCC countries recall batches of Nestle’s infant formula

    Four Gulf Cooperation Council (GCC) nations have initiated precautionary recalls of multiple Nestlé infant formula products following the detection of Bacillus cereus bacteria in a raw material ingredient. The contamination scare, which has triggered global health alerts across 37 countries, prompted coordinated action from UAE, Saudi Arabia, Kuwait, and Qatar on January 7th.

    The UAE’s Emirates Authority for Standardization and Metrology (ESMA) announced the recall of specific batches including NAN Comfort 1, NAN Optipro 1, NAN Supreme Pro 1-3, Isomil Ultima 1-3, and Alfamino formulas. This decisive action came after laboratory analysis revealed traces of cereulide-producing bacteria in production materials, though no illnesses have been reported in connection with the products.

    Saudi Arabia’s Food and Drug Authority (SFDA) simultaneously issued consumption advisories against Nestlé’s NAN, ALFAMINO, S-26 GOLD, and S-26 ULTIMA brands. The authority confirmed implementing comprehensive market withdrawal procedures in coordination with the Swiss food giant, emphasizing that the recall was initiated following Nestlé’s voluntary risk assessment notification.

    Kuwaiti and Qatari health authorities mirrored these precautions, with Kuwait clarifying that affected products were not distributed through the nation’s ration card system. Qatar’s Ministry of Public Health urged consumers to return or dispose of specified batches while maintaining continuous monitoring of laboratory results.

    Nestlé acknowledged the quality issue originated from a third-party supplier’s arachidonic acid oil component. The company has implemented global testing protocols for all potentially impacted oil mixes and established refund mechanisms for concerned consumers. Despite the extensive recall, the multinational corporation maintains that no confirmed illnesses have been linked to the products, characterizing the action as preventive consumer protection measure.

    The coordinated GCC response demonstrates heightened regional food safety vigilance, with all affected nations maintaining open communication channels with the manufacturer while conducting ongoing safety assessments.

  • UAE issues recall for some Nestle infant formula products

    UAE issues recall for some Nestle infant formula products

    The United Arab Emirates has enacted a voluntary product recall for specific batches of Nestlé infant nutrition formulas as a precautionary health measure. This action, coordinated between the Emirates Drug Establishment (EDE) and the global food manufacturer, follows the discovery of a potential microbial contaminant in a raw material used during production.

    The affected products include several lines of specialized infant formula: NAN Comfort 1, NAN Optipro 1, NAN Supreme Pro 1, 2 and 3, Isomil Ultima 1, 2 and 3, and the Alfamino range. The EDE emphasized that this recall is proactive and preventative, initiated after quality controls detected traces of Bacillus cereus bacteria, which can produce the toxin cereulide.

    This UAE recall forms part of a broader international response, with at least 37 countries across Europe, Africa, the Americas, and Asia having issued similar health advisories regarding these specific batches. National food safety authorities in Brazil, China, South Africa, Mexico, and Australia have all implemented comparable precautionary measures.

    Critical to public reassurance, the EDE confirmed that no illnesses or adverse health events related to these products have been reported within the UAE to date. All other Nestlé products remain unaffected and safe for consumption. The authority detailed that the identified batches have been immediately quarantined within Nestlé’s and distributors’ warehouses. A comprehensive process is now underway to ensure the complete removal of these products from all retail channels, including online marketplaces, to safeguard consumer health and safety in alignment with the nation’s stringent regulatory protocols.

  • More protein, less sugar: Trump administration issues new dietary guidelines

    More protein, less sugar: Trump administration issues new dietary guidelines

    In a significant shift from established nutritional policy, the Trump administration unveiled revised federal dietary guidelines on January 7, 2026, emphasizing increased protein consumption and stringent sugar limitations. The new recommendations mark a departure from conventional wisdom by endorsing full-fat dairy products and explicitly discouraging highly processed foods and artificial sweeteners.

    The guidelines, developed under Health Secretary Robert F. Kennedy Jr. and Agriculture Secretary Brooke Rollins as part of the “Make America Healthy Again” (MAHA) initiative, represent the most substantial overhaul of federal nutrition advice in decades. Secretary Kennedy declared the administration’s stance as a “war on added sugar” during the White House announcement, positioning the new guidelines as a measure to combat rising chronic disease rates linked to dietary patterns.

    Key modifications include increased protein recommendations from 0.8 grams to 1.2-1.6 grams per kilogram of body weight daily, elimination of specific alcohol consumption limits in favor of general reduction advice, and removal of the previous allowance for minimal added sugars in healthier foods. The updated guidance now states that “no amount of added sugars or non-nutritive sweeteners is recommended or considered part of a healthy or nutritious diet.”

    The administration’s approach has drawn support from medical organizations, including the American Medical Association, which applauded the focus on processed foods and sugar-sweetened beverages contributing to heart disease, diabetes, and obesity. However, the guidelines have generated controversy due to their departure from previous scientific consensus and concerns about industry influence on nutritional policy.

    These federally-mandated guidelines form the nutritional foundation for school meal programs serving approximately 30 million children and influence medical advice nationwide. The administration has indicated plans to reform the guideline development process further, including restructuring advisory committees that critics claim have been overly influenced by food industry interests.

  • Study shows how fast kilos return after ending weight-loss drugs

    Study shows how fast kilos return after ending weight-loss drugs

    A comprehensive medical review published Thursday in The BMJ reveals that patients who discontinue next-generation weight-loss medications regain previously lost weight at an accelerated rate compared to those ending traditional diet and exercise regimens. The study, conducted by Oxford University researchers, represents the most extensive analysis to date on weight rebound patterns following cessation of GLP-1 agonist drugs like Ozempic and Wegovy.

    According to the research, individuals who stopped taking semaglutide-based medications experienced weight regain at approximately four times the velocity of those abandoning conventional weight management programs. Participants in clinical trials had initially lost an average of 15 kilograms while actively using these pharmaceutical interventions. However, within one year of discontinuation, they regained approximately 10 kilograms, with projections indicating complete return to baseline weight within 18 months.

    The investigation synthesized data from 37 distinct studies examining various weight-loss pharmaceuticals, finding consistent patterns of 0.4 kilograms regained monthly after treatment cessation. Notably, cardiovascular health metrics including blood pressure and cholesterol levels similarly reverted to pre-treatment baselines within 1.4 years post-discontinuation.

    Study co-author Susan Jebb, Professor of Public Health Nutrition at Oxford University, emphasized that approximately half of patients discontinue these medications within the first year, potentially due to side effects like nausea or substantial financial burden—costs can exceed $1,000 monthly in the United States.

    Researchers clarified that while the rapid weight regain partially reflects the substantial initial weight loss achieved through pharmaceutical intervention, separate analysis confirmed that rebound velocity remained consistently faster after medication cessation regardless of initial weight reduction magnitude. This suggests that behavioral modifications through diet and exercise programs may create more sustainable lifestyle changes.

    The findings have significant implications for healthcare systems evaluating the long-term cost-effectiveness of these treatments. Experts emphasize that obesity should be approached as a chronic relapsing condition requiring lifelong management strategies rather than temporary interventions. University of Melbourne metabolic neuroscience researcher Garron Dodd, while not involved in the study, noted that sustainable treatment will likely require combination approaches and therapies that fundamentally reshape neural pathways governing energy balance.

  • UAE moves towards nationwide mandatory early cancer screening, says Minister

    UAE moves towards nationwide mandatory early cancer screening, says Minister

    The United Arab Emirates is advancing a federal strategy to implement compulsory early cancer detection screenings across the nation, connecting participation directly to health insurance requirements. Health Minister Ahmed Al Sayegh announced this significant healthcare policy shift during a Federal National Council session on Wednesday, January 7, 2026.

    Minister Al Sayegh emphasized that early cancer detection represents one of the most effective approaches for enhancing survival rates while simultaneously reducing both the economic burden and long-term health consequences of cancer. This initiative emerges amid increasing global cancer incidence rates.

    Abu Dhabi’s pioneering ‘Ifhas’ program serves as the model for this nationwide expansion. This comprehensive screening framework currently covers citizens from age 18, conducting evaluations every two to three years—or more frequently based on individual medical risk profiles. The program targets several prevalent cancers including breast, colorectal, cervical, and lung cancer, alongside preventive testing for chronic conditions such as diabetes, cardiovascular disease, and hypertension.

    The federal expansion involves standardizing preventive screening protocols across all emirates. The ‘Itmi’nan’ program, operated by Emirates Health Services, provides periodic screening for non-communicable diseases and certain cancers, and is being integrated into standard healthcare pathways with plans for enhanced scope and coverage.

    The UAE is increasingly employing cutting-edge diagnostic technologies including liquid biopsies, genetic testing, advanced laboratory diagnostics, and artificial intelligence-supported medical imaging. These technologies enable more accurate and rapid diagnoses, facilitating earlier clinical interventions and allowing healthcare providers to implement risk-based, personalized screening protocols rather than relying exclusively on age-based testing models.

    Looking toward the future, Minister Al Sayegh highlighted the National Genome Programme’s role in advancing preventive healthcare. This initiative will help medical teams identify genetic risk factors that might necessitate early monitoring or intervention, reflecting a broader national shift toward evidence-based, proactive healthcare supported by scientific and technological innovation.

    FNC member Naama Al Sharhan endorsed these efforts while emphasizing the need for stronger participation rates, particularly for cancers with high mortality rates. She noted that early detection not only improves treatment outcomes but also reduces the emotional and financial strain on families.

    The Ministry of Health and Prevention continues to refine its preventive health strategy in coordination with federal and local partners, aiming to protect public health and ensure the healthcare system’s long-term sustainability in alignment with international best practices.

  • New US dietary guidelines call for more protein, less processed food

    New US dietary guidelines call for more protein, less processed food

    The U.S. Department of Health and Human Services has introduced transformative dietary recommendations that fundamentally reshape national nutrition policy. Secretary Robert F. Kennedy Jr. presented the updated guidelines during a White House briefing, championing a “real food” philosophy that encourages increased protein consumption while dramatically reducing processed foods and added sugars.

    The comprehensive guidelines, revised quinquennially through collaboration between the Agriculture Department and Health and Human Services, now endorse three daily servings of full-fat dairy products and significantly modify alcohol consumption recommendations. These nutritional standards form the cornerstone of federal nutrition initiatives, including the National School Lunch Program and other feeding assistance programs.

    Notable shifts include the abandonment of previous low-fat dairy recommendations in favor of full-fat alternatives, representing a substantial departure from decades of nutritional guidance. The updated framework promotes olive oil as a primary cooking fat while surprisingly suggesting beef tallow—a Kennedy preference—as an acceptable alternative despite its high saturated fat content.

    Alcohol guidelines have undergone the most radical transformation, eliminating specific daily drink limits (previously one drink for women and two for men) in favor of a generalized recommendation to consume “less alcohol for better overall health.” The guidelines maintain specific prohibitions for pregnant women, those recovering from alcohol use disorder, and individuals taking incompatible medications.

    The medical community has responded with divided perspectives. The American Medical Association praised the emphasis on reducing processed foods and sugar-sweetened beverages, with President Bobby Mukkamala declaring that “the guidelines affirm that food is medicine.” However, prominent nutrition experts like former NYU professor Marion Nestle criticized the protein recommendations as unnecessary given existing consumption patterns, warning that the guidelines resemble 1950s eating patterns associated with rampant heart disease.

    The American Heart Association expressed concern that recommendations regarding salt seasoning and red meat consumption might lead consumers to exceed established limits for sodium and saturated fats—primary contributors to cardiovascular disease. These guidelines represent Kennedy’s continued focus on combating obesity and chronic illness, following his previous initiatives regarding artificial food dyes and controversial changes to vaccine policies.

  • China set to establish early pregnancy clinics across 10k hospitals

    China set to establish early pregnancy clinics across 10k hospitals

    China’s National Health Commission has announced a comprehensive healthcare expansion plan for 2026, featuring the establishment of specialized early pregnancy care clinics across 10,000 medical institutions nationwide. This initiative represents a significant advancement in promoting fertility health and developing a child-friendly society.

    The ambitious program includes creating 150,000 additional affordable nursery care slots to reduce family childcare burdens and increase enrollment rates according to regional needs. These measures address some of the most pressing concerns in China’s healthcare landscape.

    In a major public health advancement, the commission will implement free HPV vaccinations for 13-year-old girls following last September’s inclusion of the vaccine in the national immunization program. This strategic intervention aims to substantially reduce HPV infection rates and lower cervical cancer incidence in adulthood.

    To improve healthcare accessibility, immunization services will now be available at township health centers and community healthcare facilities during weekends. The commission also plans to train 3,200 healthcare professionals in integrated Western and traditional Chinese medicine, expanding access to high-quality combined medical services.

    Additional expansions will enhance pediatric, mental health, and hemodialysis services, while ensuring all major public hospitals provide comprehensive weight management programs. These coordinated efforts demonstrate China’s commitment to addressing diverse healthcare needs through a multi-faceted approach.

  • UAE: Back-to-school season could trigger rise in flu cases, doctors warn

    UAE: Back-to-school season could trigger rise in flu cases, doctors warn

    Medical professionals across the United Arab Emirates are alerting communities to anticipate a predictable increase in influenza cases coinciding with the post-holiday return to academic institutions. This annual pattern emerges as students congregate in educational environments following extensive travel and social gatherings during the winter break.

    Healthcare experts note that the convergence of children in classroom settings creates optimal conditions for viral transmission, particularly among younger demographics with developing immune systems. Dr. Mamata Bothra, Specialist in Pediatrics and Neonatology at International Modern Hospital Dubai, observed: ‘We are witnessing a marked escalation in flu-like ailments among pediatric patients shortly after school recommencement. This cyclical phenomenon remains consistent with previous epidemiological patterns.’

    The epidemiological situation mirrors developments in the United States, where the Centers for Disease Control and Prevention report escalating hospitalizations and record-breaking outpatient visits for respiratory illnesses. Although UAE authorities maintain the nation’s health status remains stable, physicians emphasize that identical seasonal factors are contributing to local transmission dynamics.

    Dr. Vishrut Singh, Pediatrics Specialist at Aster Clinic, Bur Dubai (AJMC), elaborated: ‘The current escalation represents an expected seasonal progression aligned with international travel resumption and routine transitions. Movement from holiday settings to structured educational environments naturally increases viral exposure frequency. Fortunately, most cases remain clinically manageable with enhanced community health awareness contributing to overall stability.’

    Medical recommendations emphasize proactive prevention strategies, including seasonal influenza vaccination, reinforced hygiene protocols, and parental vigilance regarding symptom monitoring. Physicians strongly advise against attending school during symptomatic periods to mitigate transmission risks. Dr. Nahed Mohamed Abdelgabaar Ali of Burjeel Medical Center, Al Shamkha emphasized: ‘Vaccination constitutes the most effective intervention for reducing influenza complications. Complementary measures including hand hygiene, respiratory etiquette, and maintaining adequate sleep and nutrition collectively support pediatric immune resilience during this vulnerable period.’

  • Nestle issues global recall of some baby formula products over toxin fears

    Nestle issues global recall of some baby formula products over toxin fears

    In a significant product safety move, multinational food conglomerate Nestlé has announced a worldwide voluntary recall of multiple infant formula brands following the potential detection of cereulide toxin. This hazardous substance, produced by specific strains of Bacillus cereus bacteria, can induce acute food poisoning symptoms including severe nausea, vomiting, and abdominal cramps upon consumption.

    The comprehensive recall affects specific batch numbers across Nestlé’s SMA infant formula and follow-on formula products distributed globally. The company has confirmed impacted products reached markets throughout Europe, including France, Germany, Austria, Denmark, Italy, and Sweden, with varying product names such as Guigoz and Nidal in France, and Beba and Alfamino in Germany.

    Nestlé emphasized that this precautionary measure follows internal quality control checks that identified potential contamination in ingredients supplied by a third-party provider. Crucially, the company stated no illness cases have been formally reported in connection with the affected batches to date.

    “The safety and wellbeing of babies remains our absolute priority,” a Nestlé representative stated. “We extend our sincere apologies for any concern or inconvenience caused to parents, caregivers, and customers worldwide.”

    The Food Standards Agency (FSA) has issued complementary guidance, warning that cereulide toxin cannot be neutralized through conventional preparation methods including boiling water or standard cooking procedures. Jane Rawling, Head of Incidents at the FSA, advised consumers to immediately discontinue use of the identified products and seek medical consultation if concerned about potential health impacts.

    Nestlé has established refund protocols for affected customers and maintains that all non-recalled products and batches remain safe for consumption. Consumers can verify batch numbers through Nestlé’s regional websites or national food safety portals, with identification codes typically located on container bases or packaging surfaces.